Tag Archives: Lung

What should people avoid inhaling during mysterious lung disease outbreak? Health officials disagree

Health officials are warning consumers about a mysterious lung disease that has sickened hundreds and killed at least three people. What to avoid? That’s where they disagree. Federal health officials are reviewing 450 possible cases linked to vaping across 33 states and one territory. At least three people have died from the illness. It’s too… Read More: What should people avoid inhaling during mysterious lung disease outbreak?… »

This Coughed-Up Blood Clot Shaped Like A Lung Tree Went Viral

It isn’t every day that a blood clot goes viral. Not viral in a virus-sense, but viral in getting many, many likes and shares on social media. But that’s what happened with a picture of a blood clot that appeared in the New England Journal and the following Tweet: A 36-year-old man was admitted to the ICU… Read More: This Coughed-Up Blood Clot Shaped Like A Lung Tree Went… »

A patient coughed up this huge blood clot that perfectly replicates the airways of his lung

A man undergoing treatment for heart failure coughed up an enormous, intact blood clot that formed a perfect cast of the air passageways of his lung. The completeness of the clot, once unfolded onto blue medical cloth, astounded doctors; they could trace the three branches of the upper lobe of the lung, the two branches… Read More: A patient coughed up this huge blood clot that perfectly… »

FDA Approves Lorbrena (lorlatinib) for Previously-Treated ALK-Positive Metastatic Non-Small Cell Lung Cancer

FDA Approves Lorbrena (lorlatinib) for Previously-Treated ALK-Positive Metastatic Non-Small Cell Lung Cancer Print this page November 2, 2018 Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved Lorbrena [lor-BREN-ah] (lorlatinib), a third-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) for patients with ALK-positive metastatic non-small cell lung cancer… Read More: FDA Approves Lorbrena (lorlatinib) for Previously-Treated ALK-Positive Metastatic Non-Small Cell… »